{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:28:13Z","timestamp":1649057293447},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1007\/bf01271200","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T04:54:13Z","timestamp":1111640053000},"page":"1153-1161","source":"Crossref","is-referenced-by-count":7,"title":["BMY-14802 reversed the ? receptor agonist-induced neck dystonia in rats"],"prefix":"10.1007","volume":"103","author":[{"given":"K.","family":"Okumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ujike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(88)90647-4","volume":"147","author":"WD Bowen","year":"1988","unstructured":"Bowen WD, Walker JM, Yashar AG, Matsumoto RR, Walker FO, Lorden JF (1988) Altered haloperidol-sensitive sigma receptors in the genetically dystonic (dt) rat. Eur J Pharmacol 147: 153?154","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(91)90830-J","volume":"204","author":"LJ Bristow","year":"1991","unstructured":"Bristow LJ, Baucutt L, Thorn L, Hutson PH, Noble A, Beer M, Middlemiss DN, Tricklebank MD (1991) Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor. Eur J Pharmacol 204: 21?28","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00427460","volume":"84","author":"G Chouinard","year":"1984","unstructured":"Chouinard G, Annable L (1984) An early phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients. Psychopharmacology (Berl) 84: 282?284","journal-title":"Psychopharmacology (Berl)"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1471-4159.1991.tb08213.x","volume":"57","author":"CD Ferris","year":"1991","unstructured":"Ferris CD, Hirsch DJ, Brooks BP, Snyder SH (1991) ?Receptors: from molecule to man. J Neurochem 57: 729?737","journal-title":"J Neurochem"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.2042-7158.1982.tb04736.x","volume":"34","author":"RM Ferris","year":"1982","unstructured":"Ferris RM, Harfenist M, McKenzie GM, Cooper B, Soroko FE, Maxwell RA (1982) BW 234U, (cis-9-[3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent. J Pharm Pharmacol 34: 388?390","journal-title":"J Pharm Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/npp.1994.5","volume":"10","author":"GR Gewirtz","year":"1994","unstructured":"Gewirtz GR, Gorman JM, Volavka J, Macaluso J, Gribkoff G, Taylor DP, Borison R (1994) BMY 14802, a sigma receptor ligand for the treatment of schizophrenia. Neuropsychopharmacology 10: 37?40","journal-title":"Neuropsychopharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1523\/JNEUROSCI.06-06-01757.1986","volume":"6","author":"AL Gundlach","year":"1986","unstructured":"Gundlach AL, Largent BL, Snyder SH (1986) Autoradiographic localization of ? receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(l-propyl)piperidine. J Neurosci 6: 1757?1770","journal-title":"J Neurosci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ddr.430030306","volume":"3","author":"W Guy","year":"1983","unstructured":"Guy W, Manov G, Wilson WH, Ban TA, Fjetland OK, Manberg PJ, Dren AT (1983) Psychotropic action of BW 234U in the treatment of inpatient schizophrenics: a doserange study. Drug Dev Res 3: 245?252","journal-title":"Drug Dev Res"},{"key":"CR9","first-page":"134","volume":"17","author":"YD Lapierre","year":"1992","unstructured":"Lapierre YD, Ancill R, Awad G, Bakish D, Beaudry P, Bloom D, Chandrasena R, Das M, Durand C, Elliott D (1992) A dose-finding study with remoxipride in the acute treatment of schizophrenic patients. J Psychiatr Neurosci 17: 134?145","journal-title":"J Psychiatr Neurosci"},{"key":"CR10","first-page":"739","volume":"238","author":"BL Largent","year":"1986","unstructured":"Largent BL, Gundlach AL, Snyder SH (1986) Pharmacological and autoradi-ographic discrimination of ? and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238: 739?748","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(88)90527-4","volume":"155","author":"BL Largent","year":"1988","unstructured":"Largent BL, Wikstrom H, Snowman AM, Snyder SH (1988) Novel antipsychotic drugs share high affinity for ? receptors. Eur J Pharmacol 155: 345?347","journal-title":"Eur J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00431718","volume":"86","author":"L Lindstrom","year":"1985","unstructured":"Lindstrom L, Besev G, Stening G, Widerlov E (1985) An open study of remoxipride, a benzamide derivative, in schizophrenia. Psychopharmacology 86: 241?243","journal-title":"Psychopharmacology"},{"key":"CR13","first-page":"124","volume":"239","author":"RT Matthews","year":"1986","unstructured":"Matthews RT, McMillen BA, Sallis R, Blair D (1986) Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. J Pharmacol Exp Ther 239: 124?131","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0447.1985.tb02585.x","volume":"72","author":"RG McCreadie","year":"1985","unstructured":"McCreadie RG, Morrison D, Eccleston D, Gall RG, Loudon J, Mitchell MJ (1985) An open multicentre study of the treatment of florid schizophrenia with remoxipride. Acta Psychiatr Scand 72: 139?143","journal-title":"Acta Psychiatr Scand"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(84)90567-3","volume":"102","author":"SO Ogren","year":"1984","unstructured":"Ogren SO, Hall H, Kohler C, Magnusson O, Lindbom LO, Angeby K, Florvall L (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 102: 459?474","journal-title":"Eur J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0447.1990.tb05294.x","volume":"358","author":"M Patris","year":"1990","unstructured":"Patris M, Agussol P, Alby JM, Brion S, Burnat G, Castelnau D, Deluermoz S, Dufour H, Ferreri M, Goudemand M (1990) A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol. Acta Psychiatr Scand [Suppl] 358: 78?82","journal-title":"Acta Psychiatr Scand [Suppl]"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(85)90856-X","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205?230","journal-title":"Brain Res"},{"key":"CR18","first-page":"403","volume":"88","author":"NMJ Rupniak","year":"1986","unstructured":"Rupniak NMJ, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88: 403?419","journal-title":"Psychopharmacology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ddr.430050412","volume":"5","author":"G Schwarcz","year":"1985","unstructured":"Schwarcz G, Halaris A, Dren A, Manberg P (1985) Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenics. Drug Dev Res 5: 387?393","journal-title":"Drug Dev Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1432-1033.1991.tb16226.x","volume":"200","author":"TP Su","year":"1991","unstructured":"Su TP (1991) ? receptors. Putative links between nervous, endocrine and immune systems. Eur J Biochem 200: 633?642","journal-title":"Eur J Biochem"},{"key":"CR21","first-page":"307","volume-title":"Advances in neuropsychiatry and psychopharmacology, 1. Schizophrenia research","author":"DP Taylor","year":"1991","unstructured":"Taylor DP, Eison MS, Moon SL, Yocca FD (1991) BMY 14802, a potential antipsychotic with selective affinity for ?-binding sites. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology, 1. Schizophrenia research. Raven Press, New York, pp 307?315"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.38.6.961","volume":"38","author":"JM Walker","year":"1988","unstructured":"Walker JM, Matsumoto RR, Bowen WD, Gans DL, Jones KD, Walker FO (1988) Evidence for a role of haloperidol-sensitive ?-?opiate? receptors in the motor effects of antipsychotic drugs. Neurology 38: 961?965","journal-title":"Neurology"},{"key":"CR23","first-page":"355","volume":"42","author":"JM Walker","year":"1990","unstructured":"Walker JM, Bowen WD, Walker FO, Matsumoto RR, De CB, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42: 355?402","journal-title":"Pharmacol Rev"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1073\/pnas.83.22.8784","volume":"83","author":"E Weber","year":"1986","unstructured":"Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (1986) 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels ?-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83: 8784?8788","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/jm00153a010","volume":"29","author":"JP Yevich","year":"1986","unstructured":"Yevich JP, New JS, Smith DW, Lobeck WG, Catt JD, Minielli JL, Eison MS, Taylor DP, Riblet LA, Temple DJ (1986) Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents. J Med Chem 29: 359?369","journal-title":"J Med Chem"},{"key":"CR26","first-page":"255","volume":"22","author":"Y Zushi","year":"1990","unstructured":"Zushi Y, Harada T, Ujike H, Okumura K (1990) Pharmacological profile of ? receptors labeled by [3H]Haloperidol for the involvement of antipsychotic and neuroprotective effects (in Japanese). Seisin-Yakuryou-Kikin 22: 255?262","journal-title":"Seisin-Yakuryou-Kikin"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01271200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01271200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T18:14:09Z","timestamp":1556648049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01271200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["BF01271200"],"URL":"https:\/\/doi.org\/10.1007\/bf01271200","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}